Showing results (11-20 of 284) with videos related to
Sort By:
Pageof 29
ACS Medicinal Chemistry Letters|November 19, 2025
Novel N‑Arylquinoline-4-carboxamide Derivatives as Prostaglandin F Receptor AntagonistsSteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
DLL3-targeted immunoPET and radioimmunotherapy ligandsSteven H LiangACS Medicinal Chemistry Letters|November 19, 2025
Novel N‑(Pyridin-3-yl)benzamide Derivatives as Histone Acyl Transferase Positive ModulatorsSteven H LiangACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel PET Tracers for Imaging Non-AD TauopathiesSteven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Novel (1H‑Pyrazol-4-ylamino)pyrimidine Derivatives as Wee1 Inhibitors for Treatment of CancerSteven H LiangACS Medicinal Chemistry Letters|September 17, 2025
Chelator Optimization and Therapeutic Potential of 188Re-FAPI for FAP-Targeted Radionuclide TherapySteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
Trop2-targeted immunoPET ligandsSteven H LiangACS Medicinal Chemistry Letters|February 19, 2025
Imaging Alpha-synuclein with Novel 5H-Imidazo[1,5-b][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's DiseaseZhendong Song, Steven H LiangACS Medicinal Chemistry Letters|March 18, 2026
Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related DiseasesHaofeng Shi, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Quinazolinone Derivatives as Potent PARP1 InhibitorsXin Zhou, Steven H LiangPageof 29